Compounded GLP-1 medications are made with the drug in the branded products but are not the same products. This guide explains what's actually different, what isn't, and what changes with FDA shortage and enforcement status.

What they have in common

What's different

When to prefer branded

When compounded is reasonable

How to evaluate a compounded provider

For an example of strong pharmacy disclosure, see our NexLife review.

Frequently asked questions

Is compounded tirzepatide or semaglutide FDA-approved?

No: compounded tirzepatide and compounded semaglutide are not FDA-approved, and FDA does not review them for safety, effectiveness or quality before they are sold, according to FDA's page on unapproved GLP-1 drugs, current as of October 1, 2026, which we read on November 21, 2026. They are made with the drug in Zepbound or Wegovy but are not the same product. A licensed 503A pharmacy may compound them for an individual prescription. FDA proposed in April 2026 to keep both off the 503B bulks list; no final decision was found as of November 20, 2026.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.